Tousignant Jennifer 4
4 · Viridian Therapeutics, Inc.\DE · Filed Jan 2, 2026
Insider Transaction Report
Form 4
Tousignant Jennifer
Chief Legal Officer
Transactions
- Sale
Common Stock
2025-12-31$31.16/sh−2,272$70,796→ 0 total
Footnotes (1)
- [F1]Consists of shares purchased under the Issuer's employee stock purchase plan.